Patenting Compounds, Compositions, and Methods for Viral Infections: Patent Eligibility Considerations and Challenges

A live 90-minute premium CLE webinar with interactive Q&A


Wednesday, October 7, 2020

1:00pm-2:30pm EDT, 10:00am-11:30am PDT

Early Registration Discount Deadline, Friday, September 11, 2020

or call 1-800-926-7926

This CLE webinar will provide guidance to patent counsel on the patenting of compounds, compositions, and methods for diagnosing and treating viral infections. The panel will discuss viral mechanisms, subject matter eligibility, and recent court treatment. The panel will also offer best practices for addressing patent eligibility issues.

Description

The COVID-19 pandemic has turned a spotlight on the issues surrounding patenting antiviral research and protecting IP rights for companies developing treatments and products to diagnose and battle viral infections. Understanding the viral mechanisms of action is critical to IP protection.

Beyond these mechanisms, patent counsel must then consider whether the antiviral and vaccine will be patent eligible. Like other patent claims, compound, composition, and method claims for viral infections must have novel, non-obvious, and useful properties. While novel compounds may often be easier to patent, vaccines include multiple layers of patents from formulations to manufacturing to methods of use.

Patent counsel and applicants must navigate the patent eligibility challenges as companies race to develop vaccines and medications to treat viral infections.

Listen as our authoritative panel of patent attorneys examines patenting issues for compounds, compositions, and methods for viral infections. The panel will discuss subject matter eligibility and recent court treatment. The panel will also offer best practices for addressing patent eligibility issues.

READ MORE

Outline

  1. Viral mechanisms
  2. Subject matter eligibility for compound, composition, and method patents
  3. Court treatment
  4. Best practices

Benefits

The panel will review these and other key issues:

  • What are the critical patentability issues when preparing compound or composition patents?
  • How have the courts treated medical diagnostics claims?
  • What strategies should counsel employ to increase the likelihood of getting patent protection for compounds, composition, or methods claims for viral infections?

Faculty

Longsworth, Gaby
Gaby L. Longsworth, Ph.D.

Director
Sterne Kessler Goldstein Fox

Dr. Longsworth is a director in the firm's Biotechnology & Chemical Practice. She is sought out by innovator...  |  Read More

Sterne, Robert
Robert Greene Sterne

Founding Director
Sterne Kessler Goldstein Fox

Mr. Sterne serves as an IP strategic advisor to start ups, emerging companies, and investors. He has authored some of...  |  Read More

Live Webinar

Buy Live Webinar
Early Discount (through 09/11/20)

Live Webinar

$297

Buy Live Webinar & Recording
Includes special savings of $300 (through 09/11/20)

Live Webinar & Download

$394

Live Webinar & DVD

$394 + $24.45 S&H

Other Formats
— Anytime, Anywhere

Early Discount (through 09/11/20)

Strafford will process CLE credit for one person on each recording. All formats include program handouts. To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video

48 hours after event

$297

Download

48 hours after event

$297

DVD

10 business days after event

$297 + $24.45 S&H